MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
MRTX
Delisted
MRTX was delisted on the 22nd of January, 2024.
81 hedge funds and large institutions have $757M invested in Mirati Therapeutics, Inc. Common Stock in 2018 Q1 according to their latest regulatory filings, with 32 funds opening new positions, 22 increasing their positions, 19 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
17% less funds holding in top 10
Funds holding in top 10: 6 → 5 (-1)
19% less call options, than puts
Call options by funds: $1.31M | Put options by funds: $1.62M
Holders
81
Holding in Top 10
5
Calls
$1.31M
Puts
$1.62M
Top Buyers
| 1 | +$36.4M | |
| 2 | +$21.1M | |
| 3 | +$11.7M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$10M |
| 5 |
PC
PointState Capital
New York
|
+$9.16M |
Top Sellers
| 1 | -$30.8M | |
| 2 | -$10.4M | |
| 3 | -$7.55M | |
| 4 |
D.E. Shaw & Co
New York
|
-$5.97M |
| 5 |
DM
Deerfield Management
New York
|
-$5.46M |